PDCD1 and neoplasm: Specifically, we focused on examining the correlation of FLT3LG with immune cell infiltration and further explored the impact of FLT3LG overexpression on the efficacy of anti-PD-1 immunotherapy in LUAD by establishing a subcutaneous tumor model of LLC cells in mice.